FDA PMA FDA Class 3 Approved 🇺🇸 United States

System, Hyperthermia, Rf/Microwave (Benign Prostatic Hyperplasia),Thermotherapy

PMA: P970008 · Supplement: S035 · Decision Mar 7, 2008
Classifications
1
FEI Numbers
10
Registration Numbers
10

Basic Information

Device Name
System, Hyperthermia, Rf/Microwave (Benign Prostatic Hyperplasia),Thermotherapy
Trade Name
UROLOGIX TARGIS SYSTEM
PMA Number
P970008
Supplement Number
S035
Device Class
FDA Class 3
Product Code
MEQ
Generic Name
System, hyperthermia, rf/microwave (benign prostatic hyperplasia),thermotherapy
Medical Specialty
Unknown
Advisory Committee
Gastroenterology, Urology
Decision
Approved
Decision Code
APPR
Decision Date
March 7, 2008
Date Received
January 9, 2008
Supplement Type
Real-Time Process
Supplement Reason
Change Design/Components/Specifications/Material
Expedited Review
N

Advisory Committee Statement

APPROVAL FOR COMPONENT CHANGES TO THE MICROWAVE GENERATOR SUBASSEMBLY USED IN THE TARGIS SYSTEM CONTROL UNIT MODEL 4000 AND IN THE COOLWAVE CONTROL UNIT MODEL 5000.

Classifications

This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

Product Code Device Name
MEQ System, Hyperthermia, Rf/Microwave (Benign Prostatic Hyperplasia),Thermotherapy